Clinical Trials Browser

Phase 3 × Not yet recruiting × Decitabine × Clear all

NCT06297772 2024-06-04

Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR

Phase 3 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute